Skip to search formSkip to main contentSkip to account menu

Osteoprotegerin test

Known as: Osteoprotegerin Measurement, OCIF, Tumor Necrosis Factor Receptor Superfamily Member 11b 
The determination of the amount of osteoprotegerin present in a sample.
National Institutes of Health

Related topics

Related topics

4 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologyTumor necrosis factor receptor 11b

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts
Osteoporosis has become one of the most prevalent and costly diseases in the world. It is a metabolic disease characterized by… 
2013
2013
Osteoblast response to nanocrystalline calcium hydroxyapatite depends on carbonate content.
Normal bone mineral is a carbonated-apatite, but there are limited data on the effect of mineral containing carbonate on cell… 
2011
2011
Serum osteoprotegerin levels are related to height loss: The Tromsø Study
Severe loss of body height is often a consequence of osteoporotic vertebral fractures. Osteoprotegerin (OPG) and receptor… 
2010
2010
The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis
The objective of this study is to investigate the relationship between soluble components of the interleukin 6 (IL-6) system… 
Highly Cited
2007
Highly Cited
2007
Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force.
The undesired movement of anchor teeth, and relapse of previously moved teeth, are major clinical problems in orthodontics… 
Highly Cited
2006
Highly Cited
2006
Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin.
2005
2005
Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
INTRODUCTION Recent studies suggest that multiple myeloma (MM) triggers osteoclastogenesis by disrupting the balance between the… 
2003
2003
Osteoprotegerin Levels in Primary Hyperparathyroidism: Effect of Parathyroidectomy and Association with Bone Metabolism
The effect of parathyroid hormone (PTH) on the production of osteoprotegerin (OPG) remains controversial. Most in vitro studies… 
2002
2002
Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand (RANKL) in the Serum of Healthy Adults
Aims Osteoprotegerin and the receptor activator of the nuclear factor-κB ligand (RANKL) are decisive factors for maintaining the… 
2000
2000
Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin.
The discovery of osteoprotegerin (OPG), osteoprotegerin ligand (OPGL), and RANK has elucidated the mechanism by which osteoblasts… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)